Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
52.92
+0.42 (0.80%)
Sep 11, 2025, 11:04 AM - Market open
Lantheus Holdings Revenue
Lantheus Holdings had revenue of $378.05M in the quarter ending June 30, 2025, a decrease of -4.07%. This brings the company's revenue in the last twelve months to $1.52B, up 5.75% year-over-year. In the year 2024, Lantheus Holdings had annual revenue of $1.53B with 18.32% growth.
Revenue (ttm)
$1.52B
Revenue Growth
+5.75%
P/S Ratio
2.38
Revenue / Employee
$1,881,996
Employees
808
Market Cap
3.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.53B | 237.48M | 18.32% |
Dec 31, 2023 | 1.30B | 361.37M | 38.65% |
Dec 31, 2022 | 935.06M | 509.85M | 119.91% |
Dec 31, 2021 | 425.21M | 85.80M | 25.28% |
Dec 31, 2020 | 339.41M | -7.93M | -2.28% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
LNTH News
- 15 hours ago - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lantheus Holdings, Inc. (LNTH) - GlobeNewsWire
- 1 day ago - LNTH LAWSUIT: Lantheus Holdings Inc. Sued For Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses - GlobeNewsWire
- 2 days ago - Lantheus Holdings, Inc. (LNTH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 7 days ago - LNTH Investors Have Opportunity to Join Lantheus Holdings, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire
- 5 weeks ago - Lantheus Holdings, Inc. (LNTH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Lantheus Holdings: Reassessing The Buy Thesis - Seeking Alpha
- 5 weeks ago - Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent - GlobeNewsWire
- 7 weeks ago - Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D - GlobeNewsWire